Fiocruz halts Covid vaccine production in Brazil for shortage of raw material
Fiocruz suspended temporarily the production of the Oxford/AstraZeneca vaccine due to a raw materia shortage, API is expected on May...
May 21, 2021
Fiocruz suspended temporarily the production of the Oxford/AstraZeneca vaccine due to a raw materia shortage, API is expected on May...
May 21, 2021
Chinese CanSino Biologics laboratory requests Brazilian Health Regulatory Agency ANVISA for emergency use of its single-dose Covid-19 vaccine
May 20, 2021
China on Tuesday reduced the volume of active pharmaceutical ingredient (API) for CoronaVac production to be shipped to Brazil from...
May 19, 2021
90 million Covid-19 vaccine doses have been distributed by Brazil's Health Ministry, although production is hampered by lack of API
May 19, 2021
Butantan Institute delivered another 1 million doses of the vaccine against the novel coronavirus to the National Immunization Program (PNI)
May 13, 2021
Chinese Coronavac API on hold for diplomatic reasons, compromising June's vaccine lots according to João Doria and Dimas Covas (São...
May 13, 2021
27% more than the April quota of doses of Covid-19 vaccines are expected for this month, according to the Brazilian...
May 10, 2021
Paraná-based Globobiotech has been providing eggs for the production of the influenza and now Covid-19 vaccines by the Butantan Institute...
May 7, 2021
The Butantan Institute may delay delivery of the CoronaVac to the Ministry of Health, the Chinese Sinovac's vaccine against Covid-19,...
May 6, 2021